GlassScriptPhysician profile
Aamir Hameed
NPI 1245241793
$3,190.05
in general payments reported to CMS, 2019-2025
14 companies · $1,626 in 2025
The $1,626 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.05 · 2020: $28.47 · 2021: $14.37 · 2022: $36.41 · 2023: $1,154 · 2024: $281 · 2025: $1,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,321 · Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,321.37 |
| Food and Beverage | $739.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,348.81 | 2025 | General - Vascular Access |
| Medtronic, INC. | $1,109.31 | 2023 | Micra |
| Amgen INC. | $173.91 | 2024-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $147.37 | 2025 | |
| Abiomed | $117.31 | 2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $114.19 | 2019-2024 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $32.80 | 2019-2022 | |
| Irhythm Technologies, INC. | $32.32 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Cardiva Medical, INC. | $29.26 | 2024 | Cardiva Vascade 6/7f Vcs |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.18 | 2025 | Lifevest |
| Baxter Healthcare | $20.66 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Pfizer INC. | $14.46 | 2024 | |
| Novartis Pharmaceuticals Corporation | $14.39 | 2023 | |
| Ancora Heart, INC. | $14.08 | 2023 | Accucinch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aamir Hameed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.